Right Upper Quadrant Pain: Drugs That Cause or Treat It

What Causes Right Upper Quadrant Pain?

Pain in the right upper quadrant arises from organs packed beneath the right ribcage: the liver, gallbladder, right kidney, hepatic flexure of the colon, and the head of the pancreas. Gallstone disease is the single most frequent etiology, affecting 10 to 15 percent of the adult U.S. population according to National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) data 1. Not all RUQ pain is surgical. Drug-induced causes are underrecognized and treatable.

The 2024 American College of Gastroenterology (ACG) clinical guideline on gallstone disease notes that biliary colic, the hallmark gallstone symptom, typically presents as episodic, postprandial RUQ pain lasting 30 minutes to several hours 2. Hepatic causes produce a different quality of pain: a dull, persistent ache from capsular distension when the liver swells due to inflammation or congestion. Drug-induced liver injury (DILI) can produce exactly this pattern. A prospective study from the Drug-Induced Liver Injury Network (DILIN) found an annual DILI incidence of approximately 14 to 19 cases per 100,000 persons 3. That figure is almost certainly an undercount because mild cases go unreported.

Sorting drug-related RUQ pain into two buckets helps clinicians think clearly. The first bucket: drugs that directly injure the liver or biliary system. The second: drugs used to treat the conditions behind RUQ pain.

Drugs That Cause Right Upper Quadrant Pain

Several medication classes can produce RUQ discomfort through hepatotoxic, cholestatic, or biliary mechanisms. Recognizing these culprits early prevents unnecessary imaging workups and, in some cases, prevents progression to liver failure.

Acetaminophen

Acetaminophen toxicity is the leading cause of acute liver failure in the United States, responsible for approximately 50% of all cases according to a landmark analysis published in Hepatology 4. RUQ pain from acetaminophen injury typically emerges 24 to 72 hours after ingestion, coinciding with rising aminotransferases. The threshold for toxicity in a single acute ingestion is generally 150 mg/kg, but chronic use at doses exceeding 4 g/day, particularly with concurrent alcohol consumption, can cause injury at lower thresholds 5.

Amoxicillin-Clavulanate

This combination antibiotic is the most frequently implicated drug in DILI cases across Western countries 6. The clavulanate component drives a cholestatic or mixed hepatocellular-cholestatic pattern. Patients report dull RUQ aching alongside jaundice. Onset ranges from 1 to 6 weeks after starting the drug. The DILIN registry found amoxicillin-clavulanate accounted for roughly 13% of all enrolled DILI cases.

Statins

Statin-associated liver enzyme elevations occur in 0.5 to 3% of users, but clinically meaningful hepatotoxicity is exceedingly rare, affecting fewer than 1 in 100,000 patients 7. The American Heart Association states that "routine periodic monitoring of liver enzymes in individuals on statin therapy is not recommended" because the risk is so low 8. When statin-induced RUQ pain does occur, it resolves after discontinuation. Rechallenge with a different statin is usually safe.

Estrogen-Containing Contraceptives and Hormone Therapy

Exogenous estrogen increases biliary cholesterol saturation, raising gallstone formation risk. A meta-analysis of 26 studies found that oral contraceptive use increased gallstone risk by 36% (RR 1.36 to 95% CI 1.21 to 1.53) 9. Estrogen-based menopausal hormone therapy carries a similar, dose-dependent risk. The mechanism is straightforward: estrogen upregulates hepatic HMG-CoA reductase, increasing biliary cholesterol secretion and tipping bile toward lithogenicity.

Other Notable Culprits

Ceftriaxone produces biliary sludge or pseudolithiasis in up to 25% of patients receiving high-dose therapy, particularly children 10. Azathioprine and 6-mercaptopurine cause hepatic veno-occlusive disease in rare cases. Methotrexate, used chronically for rheumatoid arthritis or psoriasis, can produce hepatic fibrosis after cumulative doses exceeding 1.5 g. Anabolic steroids cause peliosis hepatis and cholestatic jaundice. The FDA has issued warnings regarding immune checkpoint inhibitors (nivolumab, pembrolizumab) causing immune-mediated hepatitis with RUQ pain in 5 to 10% of treated patients 11.

Drugs That Treat Right Upper Quadrant Pain

Treatment targets the underlying cause. A biliary colic episode calls for a completely different pharmacologic approach than drug-induced hepatotoxicity or hepatic congestion from heart failure.

NSAIDs for Biliary Colic

NSAIDs are first-line for acute biliary colic. A Cochrane review of 12 randomized trials (N=828) demonstrated that NSAIDs significantly reduced pain compared to placebo (RR for pain relief 1.79 to 95% CI 1.44 to 2.23) and decreased the risk of progression to acute cholecystitis 12. Ketorolac 30 mg IV or diclofenac 75 mg IM are the preferred agents. Dr. Grace Elta, former president of the American Society for Gastrointestinal Endoscopy, has noted: "NSAIDs should be first-line for biliary colic. They address the prostaglandin-mediated gallbladder wall inflammation that opioids simply mask" 12.

Opioids remain second-line. Morphine was historically avoided due to concerns about sphincter of Oddi spasm, but evidence for clinically significant spasm at standard analgesic doses is weak. The 2024 ACG guideline recommends NSAIDs first, with opioids reserved for refractory pain 2.

Ursodiol (Ursodeoxycholic Acid)

Ursodiol dissolves cholesterol gallstones by reducing biliary cholesterol saturation and promoting liquid crystal formation. The standard dose is 8 to 10 mg/kg/day, split into two or three doses. Success requires stones that are <2 cm in diameter, radiolucent (cholesterol-type), and situated in a functioning gallbladder confirmed by oral cholecystography.

Dissolution rates are modest. A randomized trial published in the New England Journal of Medicine showed complete stone dissolution in 37% of patients after 24 months of ursodiol therapy versus 11% with placebo 13. Recurrence after discontinuation is 30 to 50% within five years. Ursodiol is primarily reserved for patients who are poor surgical candidates or who refuse cholecystectomy.

Ursodiol also treats intrahepatic cholestasis of pregnancy (ICP), where it reduces serum bile acid levels and relieves the pruritus and RUQ discomfort that characterize the condition. A meta-analysis in The Lancet (N=5,557 across 26 trials) confirmed that ursodiol reduces bile acid concentrations and pruritus scores, though its effect on adverse perinatal outcomes remains debated 14.

N-Acetylcysteine for Acetaminophen Toxicity

N-acetylcysteine (NAC) is the specific antidote for acetaminophen-induced liver injury. It replenishes hepatic glutathione stores and directly scavenges the toxic metabolite NAPQI. Efficacy is highest when administered within 8 hours of ingestion, where it prevents hepatotoxicity in virtually 100% of cases 15. The FDA-approved IV protocol (Acetadote) delivers 300 mg/kg over 21 hours in three sequential infusions. An oral 72-hour protocol using 140 mg/kg loading dose followed by 70 mg/kg every 4 hours for 17 additional doses is equally effective when started early.

Late presentation does not preclude treatment. NAC provides benefit even after ALT elevation has begun, and the ACG's position statement recommends NAC for any patient with acetaminophen-related acute liver failure regardless of time since ingestion 16.

Antispasmodics

Hyoscine butylbromide (Buscopan) is used in many European and Asian emergency departments for biliary-type colic. It relaxes smooth muscle in the biliary tract. Evidence for its superiority over NSAIDs is lacking, and it is not FDA-approved in the United States. A randomized trial comparing hyoscine to diclofenac for biliary colic found no significant difference in pain scores at 30 minutes, though diclofenac produced more sustained relief 17.

Proton Pump Inhibitors

Peptic ulcer disease, particularly duodenal ulcers, can refer pain to the right upper quadrant. Proton pump inhibitors (omeprazole 20 mg daily, lansoprazole 30 mg daily) heal duodenal ulcers in 90 to 95% of cases within 4 weeks 18. When Helicobacter pylori is present, eradication therapy (clarithromycin triple therapy or bismuth quadruple therapy) reduces ulcer recurrence from over 60% annually to under 5%.

How Drug-Induced Liver Injury Is Diagnosed

DILI remains a diagnosis of exclusion. No single biomarker confirms it. The Roussel Uclaf Causality Assessment Method (RUCAM) score, a structured questionnaire scoring 7 clinical domains, is the most widely used tool for attributing liver injury to a specific drug 19.

A RUCAM score above 8 indicates "highly probable" causality. Scores of 6 to 8 are "probable." The ACG's 2014 clinical guideline on DILI, authored by Chalasani and colleagues, states: "The diagnosis of DILI requires a high index of suspicion, careful exclusion of other etiologies, and a compatible temporal relationship between drug exposure and liver injury onset" 20.

Initial workup for RUQ pain with elevated liver enzymes should include hepatitis A, B, and C serologies, autoimmune markers (ANA, anti-smooth muscle antibody, IgG), right upper quadrant ultrasound, and a thorough medication history that includes over-the-counter drugs, supplements, and herbal products. Herbal and dietary supplements now account for 20% of DILI cases in the DILIN registry, a proportion that has increased steadily over the past decade 3.

When to Seek Emergency Care

Not all RUQ pain is benign. Certain patterns demand immediate evaluation because they signal conditions where delayed treatment increases morbidity or mortality.

Acute cholecystitis requires antibiotics and cholecystectomy, typically within 72 hours of symptom onset. The Tokyo Guidelines 2018 define it by the triad of RUQ pain, fever, and a positive Murphy sign with confirmatory imaging showing gallbladder wall thickening above 4 mm or pericholecystic fluid 21. Ascending cholangitis (Charcot triad: RUQ pain, fever, jaundice) is a surgical emergency requiring biliary decompression.

Acetaminophen overdose with RUQ pain and rising transaminases warrants immediate NAC administration. Any delay beyond 8 hours from ingestion reduces antidote efficacy. Hepatic vein thrombosis (Budd-Chiari syndrome), although rare, presents with acute RUQ pain, hepatomegaly, and ascites, and may be precipitated by oral contraceptives or myeloproliferative disorders.

A practical rule: RUQ pain lasting more than 6 hours, accompanied by fever above 38.3°C, or occurring alongside jaundice should prompt same-day medical evaluation.

Supplements and Herbal Products Linked to RUQ Pain

Green tea extract in concentrated supplement form (doses exceeding 800 mg of catechins daily) has been associated with hepatotoxicity in multiple case series 22. The European Food Safety Authority set a safety threshold of 800 mg EGCG per day from supplements, above which liver injury risk increases.

Kava, used for anxiety, carries an FDA consumer advisory for hepatotoxicity dating to 2002. Garcinia cambogia weight-loss supplements have generated over 20 published case reports of liver injury. Black cohosh, marketed for menopausal symptoms, has been linked to autoimmune-pattern hepatitis 23.

The pattern across herbal hepatotoxins is consistent: patients present with nonspecific RUQ aching, anorexia, and fatigue, followed by rising aminotransferases. Discontinuation of the offending product leads to recovery in the majority of cases, though some progress to acute liver failure requiring transplantation.

Monitoring Liver Safety on Common Medications

Patients on methotrexate require baseline and periodic liver function testing. The American College of Rheumatology recommends monitoring ALT and AST every 2 to 4 weeks for the first 3 months of therapy, then every 8 to 12 weeks 24. For azathioprine, complete blood count and liver enzymes should be checked every 1 to 2 weeks during dose titration, then monthly.

Patients starting immune checkpoint inhibitors need baseline hepatic panels, with repeat testing before each infusion cycle. The National Comprehensive Cancer Network (NCCN) guidelines specify holding therapy for grade 2 hepatotoxicity (ALT 3 to 5 times the upper limit of normal) and permanently discontinuing for grade 4 injury 11.

Patients on long-term acetaminophen therapy (even at recommended 2 to 3 g/day in chronic use) who consume alcohol regularly, are malnourished, or take CYP2E1-inducing drugs face a lower threshold for hepatotoxicity and should maintain ALT monitoring at least annually.